InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Bolte Axel, 董事长兼首席执行官. Director active across 2 companies, notably Inozyme Pharma, Inc.. Cumulatively, 9 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €232k. History available since 24 June 2021. The latest transaction was disclosed on 1 July 2025 (U). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Bolte Axel is Président-Directeur Général and has filed 9 forms in total. Across the 9 recent filings available, purchases total EUR 231598, sales are zero, and the period covered runs from 2021-06-25 to 2025-07-03. The most frequent transaction nature is Levée d'options.